Concord Drugs Share Price

BSE
CONCORD •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Concord Drugs
Concord Drugs Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Concord Drugs Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
29.29% Fall from 52W High
-12.1
Dividend yield 1yr %
0

Concord Drugs Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Concord Drugs Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
10.8 Cr
12.36 Cr
11.69 Cr
15.64 Cr
12.78 Cr

Concord Drugs Yearly Revenue

Mar 2024Mar 2023
44.93 Cr
52.09 Cr

Concord Drugs Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
0.23 Cr
0.04 Cr
0.03 Cr
-0.34 Cr
-0.24 Cr

Concord Drugs Yearly Net Profit/Loss

Mar 2024Mar 2023
0.47 Cr
0.99 Cr

Concord Drugs shareholding Pattern

Promoter
54.4%
Public
45.6%
Promoter
54.4%
Public
45.6%
Promoter
54.4%
Public
45.6%
Promoter
55.4%
Public
44.6%
Promoter
55.4%
Public
44.6%
Promoter
55.4%
Public
44.6%

Concord Drugs Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
11
5Day EMA
31.20
10Day EMA
31.40
12Day EMA
31.50
20Day EMA
31.80
26Day EMA
32.10
50Day EMA
33.00
100Day EMA
34.20
200Day EMA
35.40
5Day SMA
31.20
10Day SMA
31.40
20Day SMA
31.90
30Day SMA
32.30
50Day SMA
32.90
100Day SMA
34.80
150Day SMA
35.60
200Day SMA
36.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
11075 Rs
14600 Rs
Week Rs
8659 Rs
10753 Rs
Month Rs
9257 Rs
11022 Rs
Resistance & Support
31.25
Pivot
Resistance
First Resistance
31.96
Second Resistance
32.60
Third Resistance
33.31
Support
First Support
30.61
Second support
29.90
Third Support
29.26
Relative Strength Index
46.58
Money Flow Index
45.49
MACD
-0.62
MACD Signal
-0.62
Average True Range
2.29
Average Directional Index
15.16
Rate of Change (21)
-9.19
Rate of Change (125)
-14.63

Concord Drugs Company background

Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Read More

Concord Drugs FAQs

You can easily buy Concord Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Concord Drugs stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -